Trump’s administration reduces Biden’s proposal to cover Medicare weight loss
Wegovy presentation appears in New Colombia, Pennsylvania, USA, November 13, 2023. – Reuters Medicare and Medicaid Services said on Friday that it did not go ahead with a proposal submitted by Biden’s administration to cover Medicare for weight loss drugs such as Novo Nordisk’s Wegovy. Novo’s Novo shares declined by 1.4% in post -purchase transactions, while those of Eli Lilly who make drug obesity decreased by 3.1%. The proposal would allow more Americans to withstand new GLP-1 drugs that have been shown to reduce weight by 20% and prevent type 2 diabetes, but cost up to $ 1,000 a month
